Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
23andMe
MedTech
23andMe lands new label for cholesterol drug response report
In recent years, 23andMe has repositioned itself as a genetic testing company that does more than help users fill out their family trees.
Andrea Park
Oct 27, 2022 11:12am
The top 10 medtech M&A deals of 2021
Jan 18, 2022 3:00am
23andMe snags 3rd FDA nod for genetic cancer risk test
Jan 10, 2022 11:58am
23andMe to go public in $3.5B deal backed by Virgin
Feb 4, 2021 11:25am
23andMe to lay off 100 as sales turn: CNBC
Jan 24, 2020 10:41am
GSK bets on tech to help boost lagging R&D
Jan 21, 2020 7:25am